News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Spada Alfred P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/27/2023 |
4
| Spada Alfred P. (See Remarks) has filed a Form 4 on Histogen Inc.|
Txns:
| Granted 106,793 options to buy
@ $1.041, valued at
$111.2k
|
|
| 02/03/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/27/2020 |
4
| Spada Alfred P. (EVP, R&D and CSO) has filed a Form 4 on Histogen Inc.|
Txns:
| Paid exercise price by delivering 12,960 shares
@ $0.56, valued at
$7.3k
Exercised 31,343 restricted stock units
@ $0 |
|
| 08/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2018 |
4
| Spada Alfred P. (EVP, R&D and CSO) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Exercised 12,121 options to buy
@ $1.24, valued at
$15k
|
|
| 02/05/2018 |
4
| Spada Alfred P. (EVP, R&D and CSO) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Granted 70,000 options to buy
@ $5.17, valued at
$361.9k
|
|
| 02/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/01/2013 |
4
| Spada Alfred P. (SVP, R&D and CSO) has filed a Form 4 on Conatus Pharmaceuticals Inc|
Txns:
| Converted 44,112 shares
@ $0
Converted 363,927 preferred shares
@ $0 |
|
|
|